FDA Adverse Event Malfunction Summary report: N

ALARIS® PUMP MODULE ADMINISTRATION SET

MDR report key: 5145942 · Received October 13, 2015

Report

Report Number
9616066-2015-01264
Event Type
Malfunction
Date Received
October 13, 2015
Date of Event
September 4, 2015
Report Date
September 17, 2015
Manufacturer
CAREFUSION
Product Code
FPA
PMA / PMN Number
K944320
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

CONCOMITANT MEDICAL PRODUCTS: BAXTER, 250ML IV BAG OF 0.5% DEXTROSE LOT: C980417 EXP: DECEMBER 2016; BAXTER, 50ML IV BAG OF 0.9% SODIUM CHLORIDE LOT: P335026 EXP: NOVEMBER 2016; THERAPY DATE (B)(6) 2015. (B)(4). THE CUSTOMER¿S REPORT OF A CHECK VALVE FAILURE WAS CONFIRMED. VISUAL INSPECTION IDENTIFIED NO ANOMALIES. FUNCTIONAL TESTING IDENTIFIED A FAULTY CHECK VALVE. SUPPLIER TESTING OF THE COMPONENT REVEALED THE PRESENCE OF THREE PARTICLES LOCATED BETWEEN THE HOUSING SEAL AREA AND THE AFFIXED SILICONE DIAPHRAGM DISK. THE SIZE OF THE PARTICLES MEASURED TO BE 0.0107¿, 0.0133¿ AND 0.0132¿ LONG. THE PARTICLES WERE IDENTIFIED TO BE COMPOSED OF BASE MATERIAL MINUSIL. THE CAUSE OF THE CHECK VALVE FAILURE IS DUE TO MINUSIL PARTICLES FOUND IN THE FLUID PATH, WHICH PREVENTED THE SILICONE DIAPHRAGM FROM FULLY SEATING AGAINST THE HOUSING SEAL AREA. THE ORIGIN OF THE MINUSIL PARTICLES WERE NOT IDENTIFIED.

Additional Manufacturer Narrative · 1

CORRECTION TO INITIAL REPORTER ADDRESS.

Additional Manufacturer Narrative · 1

ALTHOUGH REQUESTED, THE AFFECTED PRODUCT HAS NOT BEEN RECEIVED. A FOLLOW UP REPORT WILL BE SUBMITTED WITH INVESTIGATION RESULTS SHOULD THE DEVICES BE RECEIVED FOR EVALUATION.

Description of Event or Problem · 1

THE CUSTOMER REPORTED A SECONDARY 50ML BAG OF DEXAMETHASONE IN NS BACKFLOWED INTO THE PRIMARY IV BAG. THE NURSE QUICKLY STOPPED THE INFUSION; OBTAINED NEW TUBING AND MEDICATION, AND THE DEXAMETHASONE WAS GIVEN WITHOUT INCIDENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
675679 ALARIS® PUMP MODULE ADMINISTRATION SET SET, ADMINISTRATION, INTRAVASCULAR FPA CAREFUSION 2426-0007 15075637

Patients

Seq Age Sex Outcome Treatment
1